HIKAL
Back to Balance Sheet
|
HIKAL Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹30 Cr | ₹33 Cr | ₹36 Cr | ₹38 Cr | ₹32 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of HIKAL ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2024 | ₹30 Cr |
Mar2023 | ₹33 Cr |
Mar2022 | ₹36 Cr |
Mar2021 | ₹38 Cr |
Mar2020 | ₹32 Cr |
How is Deferred Tax Assets / Liabilities of HIKAL Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹30 Cr | -8.19 | |
Mar2023 | ₹33 Cr | -10.14 | |
Mar2022 | ₹36 Cr | -3.13 | |
Mar2021 | ₹38 Cr | 15.93 | |
Mar2020 | ₹32 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of HIKAL
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
HIKAL | ₹3,154.0 Cr | -1.1% | -23% | -21.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹384,002.0 Cr | -2.1% | -5.8% | -6.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹164,334.0 Cr | 3.1% | -6.5% | 28.7% | Stock Analytics | |
CIPLA | ₹127,613.0 Cr | 2.2% | 3.2% | 1.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,923.0 Cr | -1.7% | NA | 9.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,437.0 Cr | 1.4% | -1.1% | -7.6% | Stock Analytics |
HIKAL Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
HIKAL | -1.1% |
-23% |
-21.6% |
SENSEX | -1.1% |
-1.7% |
-0.3% |
You may also like the below Video Courses